CFTR and cystic fibrosis: We also tested whether these alternative targets were affected by Food and Drug Administration (FDA)-approved drugs to help identify possible new therapies to restore bicarbonate secretion to CF cells as a CFTR-independent or complementary therapy for pwCF.